Ownership and insider activity for Apollomics, Inc. (APLM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements.
Price
| Price | $22.11 |
| Market Cap | $49M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38.5M | $130.6M | $46.7M | $32.7M | $32.1M | $9.8M | $3.3M |
| Short-term Investments | $35.6M | $23.7M | $47.7M | $21.9M | $5.8M | 0 | 0 |
| Receivables | $361000 | $415000 | $506000 | $547000 | $466000 | $127000 | $2.5M |
| Inventory | 0 | 0 | $2.3M | 0 | 0 | 0 | 0 |
| Total Current Assets | $75.4M | $156.7M | $99.4M | $55.8M | $39.9M | $10.3M | $6.1M |
| Property, Plant & Equipment | $2.0M | $1.9M | $1.3M | $1.5M | $586000 | $1.0M | $580000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $1.3M | $10.3M | $14.8M | $14.8M | $14.8M | $1.7M | 0 |
| Total Assets | $79.1M | $169.9M | $123.4M | $76.5M | $55.4M | $13.1M | $6.7M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | $768000 | $3.8M | $2.2M | 0 | $4.2M | 0 | 0 |
| Total Current Liabilities | $4.6M | $12.1M | $13.6M | $12.4M | $13.6M | $7.4M | $6.3M |
| Long-term Debt | $134.0M | $284.8M | $322.2M | 0 | 0 | 0 | 0 |
| Total Liabilities | $139.8M | $297.9M | $336.3M | $524.6M | $14.2M | $8.2M | $9.9M |
| Retained Earnings | -$66.7M | -$141.5M | -$235.4M | -$474.6M | -$647.0M | -$700.8M | -$711.8M |
| Total Equity | -$60.7M | -$127.9M | -$212.9M | -$448.1M | $41.2M | $4.9M | -$3.2M |
| Total Debt | $136.0M | $289.6M | $325.4M | $991000 | $4.7M | $966000 | $643000 |
| Net Debt | $61.8M | $135.2M | $230.9M | -$53.6M | -$33.2M | -$8.8M | -$2.6M |
| Working Capital | $70.9M | $144.6M | $85.8M | $43.4M | $26.4M | $2.9M | -$275000 |
Financial Health
| Debt / Equity | -0.20 |
| Current Ratio | 0.96 |
Profitability
| Return on Equity | 288.40% |
| Return on Invested Capital | -1586.77% |
| Return on Assets | -162.93% |
| Gross Margin | 100.00% |
| Operating Margin | -111.45% |
| Net Margin | -128.69% |
Related companies: ADAP · ANL · ATHA · BLRX · GOVX · ICU · LNAI
Explore sector: Healthcare · Biotechnology
More sections of APLM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks